Heparin-induced thrombocytopenia: The role of platelet activation and therapeutic implications

Seminars in Thrombosis and Hemostasis

Volumn 25, Issue 2 SUPPL. 1, 1999, Pages 67-75

  Haas, Sylvia ^a   Walenga, Jeanine M ^b   Jeske, Walter P ^b   Fareed, Jawed ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

ADP receptor antagonists; Flow cytometry; Heparin; Heparin induced thrombocytopenia; Platelets; Thrombocytopenia GPIIb IIIa inhibitors

Indexed keywords

ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; GPI 562; HEPARIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; THROMBOCYTE FACTOR 4; TICLOPIDINE; UNCLASSIFIED DRUG;

ANTICOAGULATION; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; FLOW CYTOMETRY; HEMOSTASIS; HEPARINIZATION; HUMAN; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA;

ADENOSINE TRIPHOSPHATE; ANTICOAGULANTS; BENZYLAMINES; BLOOD PLATELETS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEPARIN; HUMANS; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; THROMBOCYTOPENIA; TICLOPIDINE;

EID: 0032923965     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (51)

1. Wallis DE, Lewis BE, Pifarré R, Scanlon PJ. Active surveillance for heparin-induced thrombocytopenia and thromboembolism. Chest 1994;106:120S
2. Chong BH, Ismail F, Chesterman CN, Berndt MD. Heparin-induced thrombocytopenia: Mechanism of interaction of the heparin-dependent antibody with platelets. Br J Haematol 1989;73:235-240
3. Amiral J, Bridey F, Dreyfus M, et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemostas 1992;68:95-96
4. Warkentin TE, Chong BH, Greinacher A. Heparin-induced thrombocytopenia: Towards consensus. Thromb Haemostas 1998;79:1-7
5. Greinacher A, Pötzsch B, Amiral J, et al. Heparin-associated thrombocytopenia: Isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemostas 1994;71:247-251
6. Kelton JG, Sheridan DP, Santos AV, et al. Heparin-induced thrombocytopenia: Laboratory studies. Blood 1988;72:925-930
7. Amiral J, Wolf M, Fischer A, et al. Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes with heparin-induced thrombocytopenia. Br J Haematol 1996;92:954-959
8. Greinacher A, Michels I, Mueller-Eckhardt C. Heparin-associated thrombocytopenia: The antibody is not heparin specific. Thromb Haemostas 1992;67:545-549
9. Chamberlin JR, Lewis B, Leya F, et al. Successful treatment of heparin-associated thrombocytopenia and thrombosis using hirulog. Can J Cardiol 1995;11:511-514
10. Pifarré R, Walenga JM, Koza MJ, Khenkina Y, Fareed J. Comparative heparin-induced thrombocytopenic response with low-molecular-weight heparin and a synthetic pentasaccharide. Thromb Haemostas 1993;69:1319
11. Walenga, JM, Koza, MJ, Lewis, BE, Pifarré R. Relative heparin-induced thrombocytopenic potential of low-molecular-weight heparins and new antithrombotic agents. Clin Appl Thromb/Hemostas 1996;2(Suppl 1):521-527
12. Walenga JM, Silber I, Koza M, Pifarré R. Lack of heparin-induced thrombocytopenia response with the use of new antithrombotic agents. Blood 1991;78(Suppl 1):145(Abst)
13. Walenga JM, Koza MJ, Pifarré R. Comparative studies on heparin analogues, recombinant TFPI and thrombin inhibitors devoid of heparin-induced thrombocytopenia response. Thromb Haemostas 1995;73:970
14. Spangenberg P. Adhesion of activated platelets to polymorphonuclear leukocytes. Thromb Res 1994;74(Suppl 1):S35-S44
15. Michelson JK, Lakkis NM, Villarreal-Levy G, Hughes BJ, Smith CW, Leukocyte activation with platelet adhesion after coronary angioplasty: A mechanism for recurrent disease? J Am Coll Cardiol 1996;28:345-353
16. Kishimoto TK, Kahn J, Migaki G, et al. Regulation of L-selectin expression by membrane proximal proteolysis. Agents Actions 1995;47:121-34
17. Jy W, Mao WW, Hortsman L, Tao J, Ahn YS. Platelet micropartides bind, activate and aggregate neutrophils in vitro. Blood Cells, Molecules Disease 1995;21:217-231
18. Walenga JM, Koza ME, Shankey TV, et al. Heparin-induced thrombocytopenic potential of unfractionated heparin and low-molecular-weight heparins as measured by a flow cytometric method. Blood 1993;82(Suppl 1):612(Abst)
19. Amiral J, Bridey F, Wolf M, et al. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: A study of 44 cases. Thromb Haemostas 1995; 73:21-28
20. Chong BH, Burgess J, Ismail F. The clinical usefulness of the platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia. Thromb Haemostas 1993;69:344-350
21. Sheridan D, Carter C, Kelton JG. A diagnostic test for heparin-induced thrombocytopenia. Blood 1986;67:27-30
22. Walenga JM, Blakemore C, Hoppensleadt D, et al. Are platelet aggregation methods valid for the laboratory diagnosis of HIT? XXV Congress of the International Society of Hematology, Cancun, Mexico, April 1994
23. Warkentin TE, Hayward CPM, Smith CA, Kelly PM, Kelton JG. Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia. J Lab Clin Med 1992; 120:371-379
24. Arepally G, Reynolds C, Tomaski A, et al. Comparison of PF4/heparin ELISA assay with the 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol 1995;104:648-654
25. Bauer T, Arepally G, Konkle BA, et al. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery. Circulation 1997;95:1242-1246
26. Lindhoff-Last E, Stein M, Spiegel J, et al. Clinical relevance of heparin-platelet factor 4-antibodies in patients after vascular surgery. Ann Hematol 1997;74(Suppl II):A63(Abst)
27. Raible MD, Wolf H, Leya F, et al. Post-PTCA generation of HEPPF4 antibodies is associated with previous exposure to unfractionated heparin. Studies with the chronic administration of a LMWH. Blood 1995;86:551a(Abst)
28. Visentin GP, Malik M, Menden KA, Aster RH. A prospective study of the formation of antibodies reactive with heparin: PF4 complexes in patients treated with heparin. Blood 1994; B4(Suppl 1):80(Abst)
29. Haas S, Fareed J, Koppenhagen K, et al. Monitoring of safety and efficacy parameters in patients receiving high dose UMWH prophylaxis, Ann Hematol 1995;72(Suppl II):P173 (Abst)
30. Suh JS, Malik MI, Aster RII, Visentin GP. Characterization of the humoral response in heparin-induced thrombocytopenia. Am J Hematol 1997;54:196-201
31. Brandt JT. Platelet aggregation in heparin-induced thrombocytopenia is dependent on complement activation. Blood 1996;88:517(Abst)
32. Bennett JS, Hoxie JA, Leitman SF, Cincs DB. Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody. Proc Natl Acad Sci USA 1983;80:2417-2421
33. Coller BS. A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex. J Clin Invest 1985;76:101-108
34. Plow E-F, Pierschbacher MD, Ruoslahti E, Marguerie GA, Ginsberg MH. The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets, Proc Natl Acad Sci USA 1985;82:8057-8061
35. Ito MK, Smith AR, Lee ML. Ticlopidine: A new platelet aggregation inhibitor. Clin Pharmacol 1992;11:603-617
36. Savi P, Heilmann E, Nurden P. Clopidogrel: An antithrombotic drug acting on the ADP-dependent activation pathway of human platelets. Clin Appl Thromb/Hemostas 1996;2:35-42
37. Stewart NW, Etches WS, Boshkov LK, Gordon PA. Heparin-induced thrombocytopenia: An improved method of detection based on lumi-aggregometry. Br J Haematol 1995;91:173-177
38. Walenga JM, Jeske WP, Fasanella AR, Wood J, Bakhos M. Laboratory tests for the diagnosis of heparin-induced thrombocytopenia. Semin Thromb Hemostas 1999; 25(Suppl 1):43-50
39. Walenga JM, Lewis BE, Hoppensteadt DA, Fareed J, Bakhos M. Management of heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome. Clin Appl Thromb/Hemostas 1997;3(Suppl 1):S53-S63
40. Shattil SJ, Cunningham M, Hoxie JA. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry, Blood 1987;70:307-315
41. Ault KA, Rinder HM, Mitchell JG, et al. Correlated measurement of platelet release and aggregation in whole blood, Cytometry 1989;10:448-455
42. Abrams CS, Ellison N, Budzynski AZ, Shattil SJ. Direct detection of activated platelets and platelet-derived microparticles in humans. Blood 1990;75:128-138
43. Jennings LK, Ashmun RA, Wang WC, Dockler ME. Analysis of human platelet glycoproteins IIb/IIIa and Glanzmann's thrombasthenia in whole blood by flow cytometry. Blood 1986; 68:173-179
44. Michelson AD. Flow cytometric analysis of platelet surface glycoproteins: Phenotypically distinct subpopulations of platelets in children with chronic myeloid leukemia. J Lab Clin Med 1987;110:346-354
45. Gordon N, Thom J, Cole C, Baker R. Rapid detection of hereditary and acquired platelet storage pool deficiency by flow cytometry. Br J Haematol 1995;89:117-123
46. Konstantopoulos K, Kamat SG, Schafer AI, et al. Shear-induced platelet aggregation is inhibited by in vivo infusion of an anti-glycoprotein IIb/IIIa antibody fragment, c7E3 Fab, in patients undergoing coronary angioplasty. Circulation 1995;91:1427-1431
47. Larsson A, Lindahl TL. Inhibition of fibrinogen binding to platelets by MK-852 a new GPIIb/IIIa antagonist. Uppsala J Med Sci 1994;99:121-129
48. Østerud B. A global view on the role of monocytes and platelets in atherogenesis. Thromb Res 1997;85:1-22
49. Peyrou V, Lormeau JC, Herault JP, Herbert JM. Erythrocytes play and important role in the thrombin generation process in whole blood. Haemostasis 1996;26(Suppl. 4):606(Abst)
50. 14C scrotonin release, J Am Coll Cardiol 1997;29(Suppl A):66(Abst)
51. Polgár J, Eichler P, Greinacher A, Clemetson K. Adenosine Diphosphate (ADP) and ADP receptor play a major role in platelet activation/aggregation induced by sera from heparin-induced thrombocytopenia patients. Blood 1998;91:549-554